LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor
Author:
Ying Lihua1, Lau Agatha2, Alvira Cristina M.1, West Robert3, Cann Gordon M.1, Zhou Bin2, Kinnear Caroline2, Jan Eric4, Sarnow Peter4, Van de Rijn Matt3, Rabinovitch Marlene1
Affiliation:
1. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94305, USA 2. Department of Pediatrics, Laboratory Medicine, Pathobiology and Medicine at the University of Toronto, Ontario, Canada M5G 1X8 3. Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA 4. Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA
Abstract
Previously, we related fibronectin (Fn1) mRNA translation to an interaction between an AU-rich element in the Fn1 3′ UTR and light chain 3 (LC3) of microtubule-associated proteins 1A and 1B. Since human fibrosarcoma (HT1080) cells produce little fibronectin and LC3, we used these cells to investigate how LC3-mediated Fn1 mRNA translation might alter tumor growth. Transfection of HT1080 cells with LC3 enhanced fibronectin mRNA translation. Using polysome analysis and RNA-binding assays, we show that elevated levels of translation depend on an interaction between a triple arginine motif in LC3 and the AU-rich element in Fn1 mRNA. Wild-type but not mutant LC3 accelerated HT1080 cell growth in culture and when implanted in SCID mice. Comparison of WT LC3 with vector-transfected HT1080 cells revealed increased fibronectin-dependent proliferation, adhesion and invasion. Microarray analysis of genes differentially expressed in WT and vector-transfected control cells indicated enhanced expression of connective tissue growth factor (CTGF). Using siRNA, we show that enhanced expression of CTGF is fibronectin dependent and that LC3-mediated adhesion, invasion and proliferation are CTGF dependent. Expression profiling of soft tissue tumors revealed increased expression of both LC3 and CTGF in some locally invasive tumor types.
Publisher
The Company of Biologists
Reference60 articles.
1. Aguirre-Ghiso, J. A., Estrada, Y., Liu, D. and Ossowski, L. (2003). ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res.63, 1684-1695. 2. Aikawa, T., Gunn, J., Spong, S. M., Klaus, S. J. and Korc, M. (2006). Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol. Cancer Ther.5, 1108-1116. 3. Blom, I. E., van Dijk, A. J., Wieten, L., Duran, K., Ito, Y., Kleij, L., deNichilo, M., Rabelink, T. J., Weening, J. J., Aten, J. et al. (2001). In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. Nephrol. Dial. Transplant.16, 1139-1148. 4. Boudreau, N., Turley, E. and Rabinovitch, M. (1991). Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev. Biol.143, 235-247. 5. Cann, G., Guignabert, C., Ying, L., Deshpande, N., Bekker, J., Wang, L., Zhou, B. and Rabinovitch, M. (2008). Developmental expression of LC3α and β: Absence of fibronectin or autophagy phenotype in LC3β knockout mice. Dev. Dyn. 237, 187-195.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|